0001209191-20-054653.txt : 20201013 0001209191-20-054653.hdr.sgml : 20201013 20201013164607 ACCESSION NUMBER: 0001209191-20-054653 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201011 FILED AS OF DATE: 20201013 DATE AS OF CHANGE: 20201013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rona Jeffrey A CENTRAL INDEX KEY: 0001311404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 201236871 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-11 0 0001636651 Ovid Therapeutics Inc. OVID 0001311404 Rona Jeffrey A C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 0 1 0 0 Chief Business Officer Stock Option (Right to Buy) 5.65 2020-10-11 4 A 0 20000 0.00 A 2030-10-10 Common Stock 20000 20000 D 50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date. /s/ Danielle Mann for Jeff Rona by PoA 2020-10-13